1. Michaëlsson G, Gerdén B, Ottosson M, et al. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin. Br J Dermatol. 1993;129:667-73.
2. Sultan SJ, Ahmad QM, Sultan ST. Antigliadin antibodies in psoriasis. Australas J Dermatol. 2010;51:238-42.
3. Nagui N, El Nabarawy E, Mahgoub D,et al. Estimation of (IgA) anti-gliadin, anti-endomysium and tissue transglutaminase in the serum of patients with psoriasis. Clin Exp Dermatol. 2011;6:302-4.
4. Akbulut S, Gür G, Topal F, et al. Coeliac disease-associated antibodies in psoriasis. Ann Dermatol. 2013;25:298-303.
5. Rudsander Lindqvist U,A, Boström A, Nilsson B, Michaëlsson G. IgA antibodies to gliadin and coeliac disease in psoriatic arthritis. Rheumatology (Oxford). 2002 ;41:31-7.
6. Lundin A, Fredens K, Michaëlsson G, Venge P. The eosinophil granulocyte in psoriasis. Br J Dermatol. 1990;122:181-93.
7. Mansur AT, Göktay F, Yaşar SP. Peripheral blood eosinophilia in association with generalized pustular and erythrodermicpsoriasis. J Eur Acad Dermatol Venereol. 2008;22:451-5.
8. Kim TY, Park HJ, Kim CW. Eosinophil cationic protein (ECP) level and its correlation with eosinophil number or IgE level of peripheral blood in patients with various skin diseases. J Dermatol Sci. 1997;15:89-94.
9. Michaëlsson G, Kraaz W, Gerdén B, et al. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma. Br J Dermatol. 1996;135:371-8.
10. Michaëlsson G, Kraaz W, Hagforsen E, et al. Psoriasis patients have highly increased numbers of tryptase-positive mast cells in the duodenal stroma. Br J Dermatol. 1997;136:866-70.
11. Silverberg NB. Pediatric vitiligo. Pediatr Clin North Am. 2014 ;61:347-66.
12. Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997;136:315-8.
13. Shahmoradi Z, Najafian J, Naeini FF, Fahimipour F. Vitiligo and autoantibodies of celiac disease. Int J Prev Med. 2013;4:200-3.
14. Rodríguez-García C, González-Hernández S, Pérez-Robayna N,et al. Repigmentation of vitiligo lesions in a child with celiac disease after a gluten-free diet. Pediatr Dermatol. 2011;28:209-10.
15. Khandalavala BN, Nirmalraj MC. Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet. Case Rep Dermatol. 2014;6(3):283-7.
16. Aroni K, Voudouris S, Ioannidis E, et al. Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions. Arch Dermatol Res. 2010;302:601-7.
17. Panja SK, Bhattacharya B, Lahiri SC.Role of histamine as a toxic mediator in the pathogenesis of vitiligo. 2013 Nov;58(6):421-8.
18. Mohan GC, Silverberg JI.Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis. JAMA Dermatol. 2015;151:522-8.
19. Huang KP, Mullangi S, Guo Y, Qureshi AA.Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149:789-94.
20. Corazza GR, Andreani ML, Venturo N, et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology. 1995;109:1333-7.
21. Bardella MT, Marino R, Barbareschi M,et al. Alopecia areata and coeliac disease: no effect of a gluten-free diet on hair growth. Dermatology. 2000;200:108-10.
22. Fessatou S, Kostaki M, Karpathios T. Coeliac disease and alopecia areata in childhood. J Paediatr Child Health. 2003;39:152-4.
23. Viola F, Barbato M, Formisano M, et al. Reappearance of alopecia areata in a coeliac patient during an unintentional challenge with gluten. Minerva Gastroenterol Dietol. 1999;45:283-5. 68- Mendes FB, Hissa-Elian A, Abreu MA, Gonçalves VS. Review: dermatitis herpetiformis. An Bras Dermatol. 2013 Jul-Aug;88(4):594-9.
24.Sugamata M, Ihara T, Uchiide I. Increase of activated mast cells in human endometriosis. Am J Reprod Immunol.2005;53(3):120-5.
25.Lin KQ, Zhu LB, Zhang XM, Lin J. Role of mast cells in estrogen-mediated experimental endometriosis in rats. Zhejiang Da Xue Xue Bao Yi Xue Ban.2015 ;44:269-77
26. Zhu LB, Lin KQ, Zhang XM, Lin J. Sodium cromoglycate attenuates experimental endometriosis in rats by regulating mast cells. Zhejiang Da Xue Xue Bao Yi Xue Ban.2015;44:278-84.
27. Stephansson O, Falconer H, Ludvigsson JF. Risk of endometriosis in 11,000 women with celiac disease. Hum Reprod.2011;26:2896-901.
28.Marziali M, Venza M, Lazzaro S, et al. Gluten-free diet: a new strategy for management of painful endometriosis related symptoms? Minerva Chir.2012;67:499-50
29.Caserta D, Matteucci E, Ralli E, et al. Celiac disease and endometriosis: an insidious and worrisome association hard to diagnose: a case report. Clin Exp Obstet Gynecol.2014;41:346-8.
30.Miyake K, Maseki Y, Sahashi M. [Studies on the pathogenesis of idiopathic male infertility by testicular biopsy]. Hinyokika Kiyo. 1983 Aug;29(8):991-1004.
31. Yamamoto M, Hibi H, Miyake K. Appearance of spermatozoon after administration of mast cell blocker to a patient with azoospermia. Hinyokika Kiyo.1994 Jun;40(6):541-3.
32. Yamamoto M, Hibi H, Miyake K. New treatment of idiopathic severe oligozoospermia with mast cell blocker: results of a single-blind study. Fertil
Steril.1995 Dec;64(6):1221-3.
33. Chen SJ, Duan YG, Haidl G, Allam JP.Predomination of IL-17-producing tryptase-positive/chymase-positive mast cells in azoospermic chronic testicular inflammation. Andrologia.2015 Sep 29.
34. 34.Messing EM, Stamey TA.Interstitial cystitis: early diagnosis, pathology, and treatment. Urology.1978 Oct;12(4):381-92.
35. .Larsen S, Thompson SA, Hald T, Barnard RJ, Gilpin CJ, Dixon JS, Gosling JA. Mast cells in interstitial cystitis. Br J Urol.1982 Jun;54(3):283-6.
36. Pelikan Z, van Oers JA, Levens WJ, Fouchier SM. [The role of allergy in interstitial cystitis]. [Article in Dutch] Ned Tijdschr Geneeskd.1999 Jun 19;143(25):1289-92.
37. 37.Shorter B, Ackerman M, Varvara M, Moldwin RM. Statistical validation of the shorter-moldwin food sensitivity questionnaire for patients with interstitial cystitis/bladder pain syndrome. J Urol. 2014 Jun;191(6):1793-801.
38. Done JD, Rudick CN, Quick ML, Schaeffer AJ, Thumbikat P. Role of mast cells in male chronic pelvic pain. J Urol.2012 Apr;187(4):1473-82.
39. Graziottin A, Skaper SD, Fusco M.Mast cells in chronic inflammation, pelvic pain and depression in women. Gynecol Endocrinol.2014 Jul;30(7):472
40. Wood JD. Visceral pain: spinal afferents, enteric mast cells, enteric nervous system and stress. Curr Pharm Des. 2011; 17(16):1573-5.
41. Demir IE, Schorn S, Schremmer-Danninger E, Wang K, Kehl T, Giese NA, Algül H, Friess H, Ceyhan GO. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS One.2013;8(3):e60529.
42. Moldwin RM.Similarities between interstitial cystitis and male chronic pelvic pain syndrome.Curr Urol Rep.2002 Aug;3(4):313-8.
43. Theoharides TC, Bielory L.Mast cells and mast cell mediators as targets of dietary supplements. Ann Allergy Asthma Immunol.2004 Aug;93(2 Suppl 1):S24-34.
44. Hatting M, Galm O, Meyer M,et al. Anemia and severe thrombocytopeniain celiac disease. Med Klin (Munich).2010 ;105:249-52.
45. Olén O, Montgomery SM, Elinder G, et al. Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease. Scand J Gastroenterol.2008;43:416-22.
46. Altintas A, Pasa S, Cil T,et al. Thyroid and celiacdiseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura. Platelets.2008 ;19:252-7.
47. Massolo F, Ferrari E, Zoboli S, Venuta A. Idiopathic thrombocytopenic purpura and food allergy: a study on possible correlations.Pediatr Med Chir.1998;20:407-9.
48. Mårild K, Stephansson O, Grahnquist L,et al. Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study. J Pediatr. 2013 ;163:237-42.
49. Carlsson A, Axelsson I, Borulf S, et al. Prevalence of IgA-antigliadin antibodies and IgA-antiendomysium antibodies related to celiac diseasein children with Down syndrome. Pediatrics.1998 ;101:272-5.
50. Zachor DA, Mroczek-Musulman E, Brown P. Prevalence of celiac diseasein Down syndromein the United States. J Pediatr Gastroenterol Nutr. 2000;31:275-9.
51. Bonamico M, Mariani P, Danesi HM, et al. Prevalence and clinical picture of celiac disease in italian down syndrome patients: a multicenter study. J Pediatr Gastroenterol Nutr. 2001;33:139-43.
52. Roizen NJ, Magyar CI, Kuschner ES, et al. A Community Cross-Sectional Survey of Medical Problems in 440 Children with Down Syndrome in New York State. J Pediatr.2013 . pii: S0022-3476(13)01467-4.
53. Bade MA, Rammeloo EM, Hermans J, et al. Symptoms of disease and food allergy in children with Down syndrome Ned Tijdschr Geneeskd. 1995 ;139(33):1680-4.
54. Liu J, Divoux A, Sun J, Et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med. 2009 Aug;15(8):940-5.
55. Altintas MM, Nayer B, Walford EC., Et al. Leptin deficiency-induced obesity affects the density of mast cells in abdominal fat depots and lymph nodes in mice. Lipids Health Dis. 2012 Feb 7;11:21.
56. Moreno M, Puig J, Serrano M., Et al. Circulating tryptase as a marker for subclinical atherosclerosis in obese subjects. PLoS One. 2014 May 15;9(5):e97014.
57. Wang J, Shi GP. Mast cell stabilization: novel medication for obesity and diabetes. Diabetes Metab Res Rev. 2011 Nov;27(8):919-24. doi: 10.1002/dmrr.1272.
58. Lee JH, Han KD, Jung HM., Et al. Association Between Obesity, Abdominal Obesity, and Adiposity and the Prevalence of Atopic Dermatitis in Young Korean Adults: the Korea National Health and Nutrition Examination Survey 2008-2010. Allergy Asthma Immunol Res. 2016 Mar;8(2):107-14.
59. Yaşar A, Akın Y, Karadağ B, Yaşar B, Karacı M. Relationship Between Obesity and Asthma Control in Children Aged 4-18 years.Indian J Pediatr. 2015 Dec 22.
60. Joseph M, Elliott M, Zelicoff A, Et al. Racial disparity in the association between body mass index and self-reported asthma in children: a population-based study. J Asthma. 2016 Jan 20:1-7. [Epub ahead of print]
61. Salamati S, Martins C, Kulseng B. Baker’s yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects. Clin Obes. 2015 Feb;5(1):42-7.
62. Zhang X, Lin J, Yang X., Et al. [Investigation of osteoporosis prevalence and osteoporosis-related clinical risk factors among healthy elderlymale]. [Article in Chinese] Zhonghua Yi Xue Za Zhi. 2015 Nov;95(41):3366-9.
63. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999 Mar 13;353(9156):878-82.
64. Camus JP, Prier A, Lièvre JA, Stephan JC, Laveant C. [Mastocyte osteoporosis].[Article in French] -Rev Rhum Mal Osteoartic. 1979 Jan;46(1):29-35.
65. Lesclous P, Saffar JL.Mast cells accumulate in rat bone marrow after ovariectomy. Cells Tissues Organs. 1999;164(1):23-9.
66. Brumsen C, Papapoulos SE, Lentjes EG, Kluin PM, Hamdy NA. A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone. 2002 Nov;31(5):556-61.
67. Chiappetta N, Gruber B. The role of mast cells in osteoporosis. Semin Arthritis Rheum. 2006 Aug;36(1):32-6. Epub 2006 Jul 3.
68. Mendes FB, Hissa-Elian A, Abreu MA, Gonçalves VS. Review: dermatitis herpetiformis. An Bras Dermatol. 2013 Jul-Aug;88(4):594-9.
